Article citationsMore >>

Atherton R, Ross A, Jessop F, Williams R, Heuschkel R, Zilbauer M. Coeliac disease in children with type 1 diabetes: are current guidelines proving difficult to implement in practice? J Pediatr Gastroenterol Nutr. 2014;59:600-3.

has been cited by the following article:


Serological Markers and/or Intestinal Biopsies in the Case-finding of Celiac Disease

1Pediatric Gastroenterology and Nutrition Unit, Carmel Medical Center, B. Rappaport School of Medicine, Technion-Israel Institute of Technology, Haifa, Israel

2Aesku.Kipp Institute, Wendelsheim, Germany

International Journal of Celiac Disease. 2015, Vol. 3 No. 2, 53-55
DOI: 10.12691/ijcd-3-2-7
Copyright © 2015 Science and Education Publishing

Cite this paper:
Aaron Lerner, Sandra Neidhöfer, Torsten Matthias. Serological Markers and/or Intestinal Biopsies in the Case-finding of Celiac Disease. International Journal of Celiac Disease. 2015; 3(2):53-55. doi: 10.12691/ijcd-3-2-7.


The new 2012 ESPGHAN guidelines for the pediatric diagnosis of celiac disease (CD) unraveled and stimulated an old/new discussion on the most efficient case- finding in pediatric CD. The fine balance between reliable serological markers and the gold diagnostic standard of small bowel histology is somewhat better understood. Due to a low diagnostic rate, changes in phenotype, increased incidence, epidemiological shifts, importance of early implementation of gluten free diet to prevent complications, the case-finding of CD should be improved. Our adult gastrointestinal colleagues did not adopt ESPGHAN diagnostic criteria and within the pediatric gastroenterology community, controversies exist. The present editorial on pediatric CD complements an adult CD one. It expands on the drawbacks, limitations and criticisms of the guidelines and calls for prudency, further research and follow-up studies. Until recent observations are implemented in the future guidelines, small bowel histology should remain the gold standard for case-finding in CD.